Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors
- PMID: 21145404
- PMCID: PMC3062948
- DOI: 10.1016/j.bbmt.2010.10.023
Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors
Abstract
Preventive care guidelines are available for hematopoietic cell transplantation (HCT) survivors. We assessed adherence to these guidelines and examined factors associated with lower adherence. A questionnaire was mailed to adult HCT survivors to collect information regarding survivor health, adherence to recommended guidelines, and financial concerns. Multivariate models identified patient and transplant characteristics associated with lower adherence. Of the 3066 survivors at >2 years after HCT, 1549 (51%) responded. The median age of the respondents was 54.5 years, and the median adherence to recommended preventive care based on age- and sex-specific recommendations was 75%. Lower adherence was associated with autologous HCT, concerns about medical costs, non-white race, male sex, lower physical functioning, absence of chronic graft-versus-host disease, longer time since HCT, and poor knowledge of recommended tests. Although 98% of the respondents had medical insurance, 26% expressed concerns about medical costs and reported efforts to limit medical costs. A concern about medical costs was associated with female sex, age <65 years, absence of chronic graft-versus-host disease, and low physical and mental functional status. Future efforts to improve adherence should address concerns about medical costs and lack of knowledge, two major modifiable predictors of lower adherence to preventive care practices in HCT survivors.
2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.Biol Blood Marrow Transplant. 2010 Feb;16(2):207-14. doi: 10.1016/j.bbmt.2009.09.015. Epub 2009 Sep 23. Biol Blood Marrow Transplant. 2010. PMID: 19781657 Free PMC article.
-
Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.Transplant Cell Ther. 2023 Feb;29(2):131.e1-131.e6. doi: 10.1016/j.jtct.2022.10.028. Epub 2022 Nov 4. Transplant Cell Ther. 2023. PMID: 36336256
-
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Bone Marrow Transplant. 2012 Mar;47(3):337-41. doi: 10.1038/bmt.2012.5. Bone Marrow Transplant. 2012. PMID: 22395764 Free PMC article.
-
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.Biol Blood Marrow Transplant. 2017 Apr;23(4):538-551. doi: 10.1016/j.bbmt.2016.09.011. Epub 2016 Sep 19. Biol Blood Marrow Transplant. 2017. PMID: 27660168 Free PMC article. Review.
-
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation.Curr Hematol Malig Rep. 2022 Dec;17(6):228-242. doi: 10.1007/s11899-022-00678-0. Epub 2022 Oct 4. Curr Hematol Malig Rep. 2022. PMID: 36194316 Review.
Cited by
-
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.Biol Blood Marrow Transplant. 2012 Feb;18(2):162-71. doi: 10.1016/j.bbmt.2011.12.501. Epub 2011 Dec 10. Biol Blood Marrow Transplant. 2012. PMID: 22155139 Free PMC article.
-
Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.J Am Acad Dermatol. 2020 Sep;83(3):762-772. doi: 10.1016/j.jaad.2019.10.034. Epub 2019 Oct 22. J Am Acad Dermatol. 2020. PMID: 31654664 Free PMC article.
-
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.Biol Blood Marrow Transplant. 2019 Mar;25(3):599-605. doi: 10.1016/j.bbmt.2018.09.040. Epub 2018 Oct 5. Biol Blood Marrow Transplant. 2019. PMID: 30296479 Free PMC article.
-
Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2019 Mar;25(3):562-569. doi: 10.1016/j.bbmt.2018.10.005. Epub 2018 Oct 10. Biol Blood Marrow Transplant. 2019. PMID: 30315940 Free PMC article.
-
Late effects of blood and marrow transplantation.Haematologica. 2017 Apr;102(4):614-625. doi: 10.3324/haematol.2016.150250. Epub 2017 Feb 23. Haematologica. 2017. PMID: 28232372 Free PMC article. Review.
References
-
- Landier W, Bhatia S, Eshelman D, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979–4990. - PubMed
-
- Leisenring W, Friedman D, Flowers M, Schwartz J, Deeg H. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24:1119–1126. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical